vaccine manufacturing Pakistan

Pakistan and China have signed nine pharmaceutical agreements worth approximately $440 million, marking a significant milestone in bilateral economic cooperation and advancing the industrial collaboration envisioned under the second phase of the China-Pakistan Economic Corridor (CPEC 2.0). The agreements were signed between private-sector companies from both countries during the Pakistan-China Pharmaceutical Business-to-Business (B2B) Conference, held in the presence of Prime Minister Shehbaz Sharif. Addressing the conference, the Prime Minister said the Pakistan China Pharmaceutical Agreements would pave the way for practical investment projects in pharmaceutical manufacturing, vaccine production, biotechnology, and research and development (R&D). According to the Ministry of Information and Broadcasting, the agreements are expected to strengthen Pakistan’s healthcare industry, attract foreign investment, and promote technology transfer between the two countries. PM Says Pakistan Can Become Regional Pharmaceutical Hub Prime Minister Shehbaz Sharif said the newly signed agreements have the potential to transform Pakistan into a regional hub for producing and exporting life-saving medicines. He said increased collaboration with Chinese pharmaceutical companies would strengthen domestic manufacturing capacity, improve research capabilities, and help Pakistan expand exports of medicines to neighboring countries and other international markets. The Prime Minister noted that developing the pharmaceutical sector would not only improve healthcare services but also contribute to industrial growth, employment generation, and export earnings. He expressed confidence that the agreements would move beyond memorandums into practical projects that support sustainable economic development. CPEC 2.0 Opens New Opportunities Highlighting the long-standing partnership between Pakistan and China, PM Shehbaz said China has consistently stood by Pakistan during challenging periods and remains the country’s most trusted economic partner. He noted that China has invested more than $30 billion under the first phase of the China-Pakistan Economic Corridor (CPEC), supporting major infrastructure, energy, and transportation projects across Pakistan. The Prime Minister described the latest pharmaceutical agreements as another milestone under CPEC 2.0, which focuses on industrial cooperation, technology transfer, innovation, and private-sector investment. He congratulated the Pakistani and Chinese entrepreneurs for reaching the agreements and acknowledged the contributions of Federal Health Minister Syed Mustafa Kamal, Special Assistant to the Prime Minister Haroon Akhtar Khan, Pakistan’s Ambassador to China Khalil Hashmi, Chinese Ambassador Jiang Zaidong, government institutions, and business leaders for making the conference successful. Government Reaffirms Security for Chinese Nationals Prime Minister Shehbaz also reiterated the government’s commitment to ensuring the safety and security of Chinese nationals working on projects across Pakistan. He assured Chinese investors that comprehensive security measures remain a top government priority and reaffirmed Pakistan’s determination to provide a secure and business-friendly environment for investment. The Prime Minister also highlighted Pakistan’s diplomatic efforts in promoting regional peace, saying the country had played an important mediating role during the recent regional crisis with the support of friendly countries, particularly China. He acknowledged the contributions of Chinese President Xi Jinping and Premier Li Qiang, as well as the diplomatic engagement of Field Marshal Syed Asim Munir and Deputy Prime Minister and Foreign Minister Ishaq Dar in strengthening bilateral relations. Health Minister Sees Strong Growth Potential Earlier, the nine agreements worth $440 million were formally signed in the Prime Minister’s presence. Federal Health Minister Syed Mustafa Kamal said the conference reflected the Prime Minister’s vision of expanding Pakistan-China cooperation through private-sector partnerships. He said weeks of intensive consultations helped pave the way for productive business-to-business engagements and praised Pakistan’s Ambassador to China, Khalil Hashmi, for facilitating discussions between companies from both countries. The Health Minister said Pakistan and China possess considerable untapped potential for cooperation in pharmaceuticals, biotechnology, healthcare, and medical technology. He added that the government is committed to improving access to quality healthcare while creating a more attractive investment climate for pharmaceutical companies. He thanked Chinese firms for their confidence in Pakistan’s pharmaceutical sector and welcomed further collaboration. Chinese Ambassador Highlights Investment Opportunities Chinese Ambassador Jiang Zaidong said Pakistan’s large and growing population has created significant demand for healthcare services, making its pharmaceutical industry an attractive destination for investment. He said the Chinese Embassy is actively working to connect businesses from both countries and encourage greater commercial cooperation. The ambassador also welcomed Pakistan’s improving economic indicators and appreciated Islamabad’s constructive role in recent regional developments. He expressed confidence that Pakistan would continue to provide a stable, secure, and investor-friendly environment for Chinese enterprises. Innovation and Technology Transfer at the Core Special Assistant to the Prime Minister on Industries and Production Haroon Akhtar Khan said Pakistan is pursuing innovation-led industrial development, with a strong emphasis on implementation, technology transfer, and global competitiveness. He noted that the Prime Minister’s recent visit to China had opened new avenues for industrial cooperation and investment. Haroon Akhtar said pharmaceuticals, biotechnology, and vaccine manufacturing have been identified as strategic industrial priorities under the government’s economic agenda. He added that reforms aimed at reducing bureaucracy and improving the ease of doing business are expected to attract additional foreign investment. Inviting Chinese companies to deepen their presence in Pakistan, he said both countries could jointly expand research, manufacturing, and export capabilities to serve regional and global markets. Outlook The Pakistan China Pharmaceutical Agreements highlight the growing diversification of bilateral cooperation beyond infrastructure, with both countries seeking to strengthen partnerships in healthcare, advanced manufacturing, biotechnology, and innovation under CPEC 2.0.